Nektar Therapeutics | NKTR - Gross Profit On Sales

Stock Price
83.22
Daily Change
1.96 2.41%
Monthly
15.25%
Yearly
814.30%
Q2 Forecast
75.38

Nektar Therapeutics reported $21.81M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Agios Pharmaceuticals USD 18.09M 6.89M Dec/2025
ALKERMES USD 338.34M 72.51M Dec/2025
Amgen USD 6.48B 307M Sep/2025
Baxter International USD 577M 373M Dec/2025
BioCryst Pharmaceuticals USD 153.05M 4.16M Dec/2025
Biogen USD 1.65B 34.6M Dec/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Cipla INR 41.64B 6.31B Dec/2025
Dr.Reddys Laboratories INR 51.37B 629M Dec/2025
Eisai JPY 168.85B 17.02B Dec/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Esperion Therapeutics USD 140.59M 94.57M Dec/2025
Exelixis USD 572.18M 7M Dec/2025
Gilead Sciences USD 6.31B 106M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Grifols EUR 766.49M 39.74M Dec/2024
Halozyme Therapeutics USD 281.77M 2.41M Sep/2025
Incyte USD 1.39B 118.68M Dec/2025
Ionis Pharmaceuticals USD 195M 40M Dec/2025
Ironwood Pharmaceuticals USD 85.24M 44.1M Jun/2025
Karyopharm Therapeutics USD 32.6M 63.38M Dec/2025
MacroGenics USD 31.11M 30.14M Dec/2025
Merck USD 13.42B 431M Sep/2025
Nektar Therapeutics USD 21.81M 8.06M Dec/2025
Neurocrine Biosciences USD 787.9M 7M Dec/2025
Novartis USD 10.25B 570M Dec/2025
Pfizer USD 3.54B 7.61B Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sarepta Therapeutics USD 43.55M 204.36M Dec/2025
Takeda JPY 790.55B 262.97B Dec/2025
Teva Pharmaceutical Industries USD 2.66B 351M Dec/2025
Xencor USD 21M 22.61M Sep/2025